Literature DB >> 15895448

Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer.

Henk H Hartgrink1, Cornelis J H van de Velde.   

Abstract

There are many factors that are of influence on gastric cancer treatment. The only way to survive is complete locoregional control. More extended dissections should lead to better outcome, but increased morbidity and mortality probably offset its long-term effect in survival in randomised studies. In this article the factors of influence on outcome of gastric cancer treatment such as the extent of lymph node dissection, splenectomy, pancreatectomy, age, volume and additional treatments are discussed. A literature review of these factors in relation to the latest results of the Dutch Gastric Cancer Trials are presented. If morbidity and mortality can be reduced there might be an advantage of extended lymph node dissection. Splenectomy and pancreatectomy should be performed only in case of direct in growth from the tumour into these organs. Centralisation of gastric cancer treatment should be achieved in order to improve results and to facilitate research. By refining selection criteria in the treatment of gastric cancer further improvements are to be expected. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Year:  2005        PMID: 15895448     DOI: 10.1002/jso.20222

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  23 in total

1.  Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance.

Authors:  John Griniatsos; Othon Michail; Nikoletta Dimitriou; Ioannis Karavokyros
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

2.  A decade in gastric cancer curative surgery: Evidence of progress (1999-2009).

Authors:  Stefano Rausei; Gianlorenzo Dionigi; Francesca Rovera; Luigi Boni; Caterina Valerii; Luisa Giavarini; Francesco Frattini; Renzo Dionigi
Journal:  World J Gastrointest Surg       Date:  2012-03-27

3.  Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis.

Authors:  Jingyu Deng; Han Liang; Dan Sun; Yi Pan; Yong Liu; Dianchang Wang
Journal:  Langenbecks Arch Surg       Date:  2011-03-05       Impact factor: 3.445

4.  Is it necessary to dissect the lymph nodes around an abnormal hepatic artery in D2 lymphadenectomy for gastric cancer?

Authors:  Y Huang; C Liu; J L Lin; G C Mu; Y Zeng
Journal:  Clin Transl Oncol       Date:  2012-11-10       Impact factor: 3.405

5.  Vascularizing lymph node dissection for advanced gastric cancer: A single-institution experience.

Authors:  Fang-Hai Han; Sheng-Ning Zhou; Hong-Ming Li; Yu-Long He; Wen-Hua Zhan
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

6.  Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery.

Authors:  Changhua Yu; Ren Yu; Weiguo Zhu; Yaqi Song; Tao Li
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-22       Impact factor: 4.553

7.  Results of specialization in the surgical treatment of gastric cancer in Peru.

Authors:  Michel Portanova; Fernando Vargas; Emilio Lombardi; Victor Mena; Ramiro Carbajal; Nestor Palacios; Jorge Orrego
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

8.  Routine modified D2 lymphadenectomy performance in pT1-T2N0 gastric cancer.

Authors:  John Griniatsos; Hara Gakiopoulou; Eugenia Yiannakopoulou; Nikoletta Dimitriou; Gerasimos Douridas; Afrodite Nonni; Theodoros Liakakos; Evangelos Felekouras
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

9.  Heat shock protein 27 expression is inversely correlated with atrophic gastritis and intraepithelial neoplasia.

Authors:  Yoshiaki Nagata; Masatoshi Kudo; Tomoyuki Nagai; Tomohiro Watanabe; Masanori Kawasaki; Yutaka Asakuma; Satoru Hagiwara; Naoshi Nishida; Shigenaga Matsui; Hiroshi Kashida; Toshiharu Sakurai
Journal:  Dig Dis Sci       Date:  2012-08-11       Impact factor: 3.199

Review 10.  Clinical significance of lymph node metastasis in gastric cancer.

Authors:  Jing-Yu Deng; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.